The Risks Behind the Expansion This approach is powerful, but not perfect
Different treatment modalities for CO CP do not seem to affect the development of endocrine deficiencies
H2 blockers, Medline Plus Famotidine, StatPearls Proton pump inhibitors, Medline Plus Omeprazole, StatPearls Prilosec OTC prescribing label, Food and Drug Administration Orange Book, Food and Drug Administration Esophagitis, StatPearls Gastric acid hypersecretory states: recent insights and advances, Current Gastroenterology Reports (2009) Pepcid AC Maximum Strength prescribing label, Food and Drug Administration Helicobacter pylori infections, Medline Plus Omeprazole, Papich Handbook of Veterinary Drugs (2021) Omeprazole versus famotidine in the healing and relapse of duodenal ulcer, Alimentary Pharmacology & Therapeutics (1993) Standard-dose proton pump inhibitors in the initial non-eradication treatment of duodenal ulcer: systematic review, network meta-analysis, and cost-effectiveness analysis, Frontiers in Pharmacology (2019) H2 receptor antagonists versus proton pump inhibitors in patients on dual antiplatelet therapy for coronary artery disease: a systematic review, Cardiology (2018) Clopidogrel tablet prescribing information, Food and Drug Administration Famotidine tablet prescribing information, DailyMed Omeprazole capsule prescribing information, DailyMed Histamine-2 receptor antagonist vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit, JAMA Internal Medicine (2014) About C
Basic fibroblast growth factor (bFGF) protects the blood-brain barrier by binding of FGFR1 and Activating the ERK signaling pathway after intra-abdominal hypertension and traumatic brain injury
